JP2024518447A5 - - Google Patents

Info

Publication number
JP2024518447A5
JP2024518447A5 JP2023568613A JP2023568613A JP2024518447A5 JP 2024518447 A5 JP2024518447 A5 JP 2024518447A5 JP 2023568613 A JP2023568613 A JP 2023568613A JP 2023568613 A JP2023568613 A JP 2023568613A JP 2024518447 A5 JP2024518447 A5 JP 2024518447A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
haloalkyl
halogen
stereoisomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023568613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518447A (ja
JP7874663B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2022/051167 external-priority patent/WO2022234299A1/en
Publication of JP2024518447A publication Critical patent/JP2024518447A/ja
Publication of JP2024518447A5 publication Critical patent/JP2024518447A5/ja
Application granted granted Critical
Publication of JP7874663B2 publication Critical patent/JP7874663B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023568613A 2021-05-06 2022-05-06 PKC-θモジュレーター Active JP7874663B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2106486.0 2021-05-06
GB202106486 2021-05-06
PCT/GB2022/051167 WO2022234299A1 (en) 2021-05-06 2022-05-06 Pkc-theta modulators

Publications (3)

Publication Number Publication Date
JP2024518447A JP2024518447A (ja) 2024-05-01
JP2024518447A5 true JP2024518447A5 (cg-RX-API-DMAC7.html) 2025-11-18
JP7874663B2 JP7874663B2 (ja) 2026-06-16

Family

ID=82100804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568613A Active JP7874663B2 (ja) 2021-05-06 2022-05-06 PKC-θモジュレーター

Country Status (14)

Country Link
US (1) US20240239794A1 (cg-RX-API-DMAC7.html)
EP (1) EP4334316A1 (cg-RX-API-DMAC7.html)
JP (1) JP7874663B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240024063A (cg-RX-API-DMAC7.html)
CN (1) CN117295738A (cg-RX-API-DMAC7.html)
AU (1) AU2022269348A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023022883A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214088A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023003247A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023015005A2 (cg-RX-API-DMAC7.html)
IL (1) IL307669A (cg-RX-API-DMAC7.html)
MX (1) MX2023013012A (cg-RX-API-DMAC7.html)
PE (1) PE20250019A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022234299A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240262821A1 (en) * 2021-05-06 2024-08-08 Exscientia Al Limited PKC-Theta Modulators
CN118772140B (zh) * 2023-04-07 2026-04-17 四川大学 一类化合物及其在治疗hDHODH介导的疾病中的用途
WO2025255294A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use
WO2025255298A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173635B2 (en) * 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors
GB0920382D0 (en) 2009-11-20 2010-01-06 Univ Dundee Design of molecules
AU2010352577A1 (en) * 2010-05-05 2012-01-19 Vertex Pharmaceuticals Incorporated 4 substituted pyrazolopyrimidines useful as PKC-theta inhibitors
RU2016129380A (ru) 2013-12-20 2018-01-25 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
EP3976612A4 (en) * 2019-05-28 2023-04-26 Mankind Pharma Ltd NEW COMPOUNDS FOR INHIBITION OF JANUS KINASE 1
US20240262821A1 (en) * 2021-05-06 2024-08-08 Exscientia Al Limited PKC-Theta Modulators

Similar Documents

Publication Publication Date Title
JP2024517861A5 (cg-RX-API-DMAC7.html)
JP2024543983A5 (cg-RX-API-DMAC7.html)
JP2023550122A5 (cg-RX-API-DMAC7.html)
JP2023509422A5 (cg-RX-API-DMAC7.html)
JP2021523221A5 (cg-RX-API-DMAC7.html)
RU2430923C2 (ru) Тиазолилдигидрохиназолины
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
RU2004126671A (ru) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
CA2672373A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
SI2961736T1 (en) Histone demethylase inhibitors
KR20160115991A (ko) Midh1 억제제로서의 벤즈이미다졸-2-아민
RU2011108932A (ru) Карбазольные соединения и терапевтические применения соединений
JP2022504620A5 (cg-RX-API-DMAC7.html)
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
JP2023513373A5 (cg-RX-API-DMAC7.html)
CN111601797A (zh) 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用
SE0201937D0 (sv) Therapeutic agents
CA2547347A1 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
JP2015500856A5 (cg-RX-API-DMAC7.html)
JP2023528073A (ja) Gpr65モジュレーターとしてのn-フェニルアミノカルボニル、ピリジノ-、ピリミジノ及びベンゾトロパン
JP2024542881A5 (cg-RX-API-DMAC7.html)
JP2023531411A5 (cg-RX-API-DMAC7.html)
JP2024112835A5 (cg-RX-API-DMAC7.html)
JP2026503618A5 (cg-RX-API-DMAC7.html)